抗体效价(log2) + D2 ^- e2 S$ \+ Q. X
| 攻毒数
8 W: s! s$ j8 f | 死亡数
" _+ e* `( B4 O | 存活数
6 X" T: }- N$ F" s, b- c3 o | 保护率%
7 M9 i+ q" C( B1 J0 Z) A" |6 [ |
0
) u1 I( \9 b) ], S2 r4 l! C | 63 E5 L: L$ C U7 O; D
| 6
U# [6 ~5 z& I+ I8 O | 0
/ @. F: L/ N5 `2 ^ | 0
' q; m) W4 T# r3 X' s4 T2 {9 x |
1
* H5 L, A' t6 f- _% D | 6
% `$ Q5 }) `& s; ]# Y3 U" }, g: I | 6
. d X5 d6 h0 y5 B) [! @, S | 0
2 _- S1 l; m* j, T- W; `- F | 0: K8 D; A8 S$ C9 G9 x
|
2
3 z4 i; L- H) C% M3 v6 H4 y | 6
3 c' J; \$ j+ I' I: T | 3 5 r$ Q) x3 F$ {# u) V7 ]; e
| 3 1 O/ o; l8 D$ W: b( y. Q8 ?
| 50
! }0 w- ]9 m# L( Z1 s |
3
8 R5 A% `' k! i; V6 `( k | 6
2 W. h# I* D: c5 |, a4 a. g5 E d" x | 0 ! b9 R* g% p8 X; `4 r% f
| 6
7 n1 C0 r/ I2 ] | 100
; I" G* F( l" _: o1 q |
4 7 v5 O- ?7 k; D- c" e
| 6
0 R: E1 @( O5 E | 0
) \ G5 L( b5 i$ _% y1 r( f6 D. V | 6 - Y! n# |- L1 P& x, S
| 100 ! I) ]3 S7 v3 m/ t
|
* v4 ^/ z4 _, L9 I
日龄
d$ g/ c3 s; m/ |! g | * r" N0 p; f; T1 A B* O3 E& e& p
免疫后
) x7 x" `* ~- M- [2 }/ v |
1周 7 I% p3 G5 h" Q" ?
| 2周
! a2 [" ^0 n; w; ~3 Q | 3周 ) H4 O) d1 \+ Q. `1 F2 Y, ]- o. n
| 4周
/ o5 N/ O6 J( L% l6 o | 5周 ! K7 y1 j- Q% U$ E; Z# A
| 6周
7 }& M9 P5 {0 D) S# v2 ] | 7周
1 w' I: } `( G( R1 L0 V | 8周 ' \4 D9 P) h) Y. y: l6 W
|
30
4 _$ a0 V n; _9 e | 1.67±0.58c
& K$ ?8 m# @5 T1 v | 2.75±0.96bc
- d2 K0 V4 P1 W; a4 s7 c, [ | 1.75±0.96b
5 N0 {9 Y; b2 }' | N | 1.00±0.00d# W8 T; _ K9 {0 I
| 0.25±0.50c$ t' B' K" X: X6 ?) S/ Q) K
| 0.13±0.25c( I. M$ N( R1 t; D& F, _ U
| 0
: s$ [0 s: M; [" I2 p | 0
) K6 H c7 i/ n$ {: u |
35- D3 L1 T8 i5 K9 |" d
| 3.25±0.50ab
# \8 ]7 X, \! M" R. i | 3.00±0.82bc* @# p2 N! _- _; \6 l: h9 G$ ^) O
| 2.38±0.49b4 D& U' S: S% V, a5 }' [7 l
| 2.00±0.00c6 P4 n: C9 b# j. E5 ]
| 1.00±0.00c6 |: x% S: J% E9 A
| 0.75±0.50c; y' b, O2 c0 b* P# n/ \
| 0
8 ]4 p0 \: O, m5 U+ z6 o7 ` | 0
1 A3 H5 s" ^ U+ t9 d, @ |
405 o: D- p) T! D4 ^1 Y
| 3.00±0.82ab
- f G/ o, X4 Y* p | 5.75±1.71a
) g0 J6 `/ }3 M) @ | 5.00±1.83a
% q+ M$ t9 n2 t3 q, X4 l8 s( S | 3.25±1.50b
- l" V# I& W+ s0 x2 P7 Y4 ~ | 3.00±0.82b
8 g4 j! J/ K. U5 i6 X6 f | 2.13±0.50b% V0 n9 g9 Z7 J9 z! b( ^( N7 I
| 1.83±0.58bc5 Q' }6 p, U: V7 u8 ?
| 1.03±0.63bc" {7 j1 ~- A8 W/ d) [! A& s ]
|
45$ A- T- ]( G7 j
| 3.25±1.26ab6 j3 \) }5 O, [' N$ q, T
| 4.25±0.96ab: {- E6 T' s7 t
| 5.50±1.29a1 S8 u+ d T! O3 F7 W4 o
| 3.75±0.96b
& A( f) \1 [6 {& C | 3.25±1.26b
2 X+ u& L, D% Q! g5 `: a | 2.38±1.80b
3 g6 e z9 V; D3 S8 c5 n- C | 2.00±1.41bc
1 k- Z9 r; E! l7 L" k$ j: f | 1.13±0.63bc+ F5 i$ t {9 m& T; h
|
50
_: \9 c+ x3 @% n& A: v1 C | 2.25±0.50bc
! E0 X0 k; c4 [/ G2 d! ^ | 4.25±0.96ab+ a' ?/ u- N4 w. e
| 4.50±2.08a6 {' f4 a x" N" y Y* `
| 5.75±0.50a6 w# g& ~( _+ } N9 [( r6 E
| 6.00±0.00a
) y+ f6 a3 O2 @2 i | 5.00±0.00a. J: q W' E* p+ U+ I
| 3.5±0.58ab
) K- W" H& ^% Q' B J; M: _$ b8 C9 X | 1.50±0.58b& v! G3 j* |, m7 Z- x9 k
|
550 V) [ S- P, T
| 3.50±0.58a' _; M. A: ]$ i7 h n1 M
| 4.75±0.50a
6 h- {* P4 c( [8 R3 Q; o# v# G | 6.00±0.82b
* T5 x4 ?2 S' T3 k) p9 I9 F | 5.75±1.50a
& L% L: m) x0 Q- g/ S5 O$ w | 5.25±0.96a
' p1 G8 l) d1 c) f1 x/ L | 4.25±0.50a
) r0 ]7 L2 ?$ p8 L1 V | 3.25±0.96b1 A. x" N9 P; k" c8 F, V
| 2.75±1.26ab! e$ `1 d- x A9 g2 ^ V
|
60, P+ o0 O3 f# K* v# u
| 3.50±0.58a1 `. u1 e2 \& u
| 5.00±0.82a d3 ]2 G0 W3 b/ S
| 6.25±0.50a6 g/ B2 R- {, \
| 5.75±0.96a
& x* `% d, V5 ~- o) U0 Y# N | 5.00±0.82a
( Z( E- i8 o9 t j! p" s | 4.13±0.85a
/ g1 f4 W6 f$ p# F$ m9 i: G+ W | 3.25±0.96b
8 |2 C6 {" t( P- n+ E' o | 2.25±0.96b6 X2 h( t& e) A
|